Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chiron Announces Termination of SEC Investigation.


EMERYVILLE, Calif. -- Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents.  (Nasdaq:CHIR CHIR Chiricahua National Monument (US National Park Service) ) today announced that the staff of the Securities and Exchange Commission (SEC) has decided to terminate its investigation of whether Chiron violated any federal securities laws in connection with the previous suspension by the UK Medicines and Healthcare products Regulatory Agency The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government agency which is responsible for ensuring that medicines and medical devices work and are acceptably safe.  (MHRA MHRA Medicines and Healthcare Products Regulatory Agency
MHRA Modern Humanities Research Association (United Kingdom)
MHRA Minnesota Human Rights Act
MHRA Malta Hotels and Restaurants Association
) of Chiron's license to manufacture FLUVIRIN(R) influenza virus vaccine influenza virus vaccine
n.
A vaccine containing influenza virus, usually several strains of the virus, prepared in chick embryos and used to immunize against influenza.
 and has ended its inquiry into the company's restatement of financial results for the second and third quarters of 2004. Chiron has been informed that no enforcement action has been recommended against the company in connection with these matters.

About Chiron

Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives. For more information about Chiron, please visit www.chiron.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 7, 2006
Words:147
Previous Article:Merck Launches New Consumer Health Resource, Guide to Affordable Medicine; Provides Information to Help 45 Million Uninsured Americans Obtain the...
Next Article:Affymetrix and Iconix Collaborate to Develop New Solutions for Assessing Drug Toxicity.
Topics:



Related Articles
Tax Matters Partner.
Chiron Revises Reconciliation of Pro-Forma and GAAP Full-Year 2004 Earnings Guidance.
Chiron Responds to FDA Announcement; Company Committed to Taking Appropriate Action to Return to Market as Reliable Supplier of Influenza Vaccine.
BRIEFCASE DISNEY RELEASING MORE VIDEO GAMES.
Chiron Testifies to House Committee on Government Reform; President and CEO Howard Pien to Appear at Hearing Today.
Chiron Receives FDA Warning Letter.
Responding to an SEC investigation: two attorneys review the dangers posed by an SEC probe, and the ways in which public companies could and should...
FDA Requests Additional Data on PULMINIQ(TM) (Cyclosporine, USP) Inhalation Solution; Agency Action Letter States that PULMINIQ is ''Approvable'' But...
U.S. Federal Trade Commission Approves Early Termination of Hart-Scott-Rodino Waiting Period.
Chiron Updates Delivery Expectations for U.S. Government H5N1 Vaccine Stockpile Contract.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles